Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Synthetic method of (2S,5S or 5R)-N-tert-butoxycarbonyl-5-hydroxy-2-piperidinecarboxylic acid ethyl ester

A technology of ethyl piperidinecarboxylate and tert-butoxycarbonyl, which is applied in the field of pharmaceutical intermediate synthesis, can solve problems such as difficulty in realizing large-scale production, long synthesis routes, expensive reagents, etc., and achieves advantages of large-scale production, easy operation, Inexpensive effect

Active Publication Date: 2018-07-03
ZHEJIANG MEDICINE CO LTD XINCHANG PHAMACEUTICAL FACTORY
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] This synthetic method has a long synthetic route, expensive reagents used in the reaction, and the two chiral centers need to be split twice, resulting in a low yield and difficult to achieve large-scale production
[0013] In summary, the methods for the synthesis of (2S,5S)-N-tert-butoxycarbonyl-5-hydroxyl-2-piperidinecarboxylic acid ethyl esters reported in the above literature all have obvious deficiencies, and the difficulty lies in the cis-piperidine six-membered ring Therefore, there is an urgent need to develop a method for the preparation of (2S, 5S)-N-tert-butoxycarbonyl-5-hydroxyl-2-piperidinecarboxylate with environmental friendliness, good selectivity, good yield and low cost

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthetic method of (2S,5S or 5R)-N-tert-butoxycarbonyl-5-hydroxy-2-piperidinecarboxylic acid ethyl ester
  • Synthetic method of (2S,5S or 5R)-N-tert-butoxycarbonyl-5-hydroxy-2-piperidinecarboxylic acid ethyl ester
  • Synthetic method of (2S,5S or 5R)-N-tert-butoxycarbonyl-5-hydroxy-2-piperidinecarboxylic acid ethyl ester

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0045] The present invention will be further described in conjunction with specific embodiments, but the content of the present invention is not limited by this embodiment.

[0046] 1.5-Hydroxy-2-pyridinecarboxylic acid ethyl ester hydrochloride (abbreviated as compound 1)

[0047]

[0048] Add 5-hydroxy-2-picolinic acid (20g, 143.8mmol) and 200ml ethanol to a 500ml single-neck flask, stir and heat to reflux. Thionyl chloride (52.2ml, 719mmol) was slowly added dropwise to the reaction solution, kept refluxed until the reaction was complete, and the solvent was removed by rotary evaporation under reduced pressure to obtain compound 1 (27.5g, 93.9%). 1 H NMR(500MHZ, DMSO-d 6 ): 8.30 (d, 1H), 8.02 (d, 1H), 7.47 (dd, 1H), 4.32 (q, 2H), 1.32 (t, 3H); MS (m / z): 168.1 [M+1] + .

[0049] Synthesis of ethyl 2.5-hydroxy-2-piperidinecarboxylate hydrochloride (abbreviated as compound 2)

[0050]

[0051] Compound 1 (27.5g, 135mmol), rhodium carbon (2.75g, 10% Rh / C) and 150ml of ethanol were added...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a synthetic method of (2S,5S or 5R)-N-tert-butoxycarbonyl-5-hydroxy-2-piperidinecarboxylic acid ethyl ester. Existing methods for synthesizing (2S,5S or 5R)-N-tert-butoxycarbonyl-5-hydroxy-2-piperidinecarboxylic acid ethyl ester have obvious deficiencies and further have difficulty in the construction of cis-piperidine acid hexatomic rings. According to the synthetic method, (2S,5S)-N-tert-butoxycarbonyl-5-hydroxy-2-piperidinecarboxylic acid ethyl ester or / and (2S, 5R)-N-tert-butoxycarbonyl-5-hydroxy-2-piperidinecarboxylic acid ethyl ester is / are prepared from a starting raw material, namely 5-hydroxy-2-pyridine carboxylic acid through nine steps of esterification salinization, reduction, Boc treatment, oxygen, protection treatment, lipase chiral resolution, Boc treatment, deprotection and reductase reduction. The synthetic method has the beneficial effects that reaction conditions are mild and easily controlled, the operation is simple and convenient, adopted reaction reagents are cheap, the production cost is greatly lowered, reaction byproducts are relatively low in toxicity and environmentally friendly, and the method is beneficial to the large-scale production.

Description

Technical field [0001] The invention belongs to the field of synthesis of pharmaceutical intermediates, specifically a (2S,5S)-N-tert-butoxycarbonyl-5-hydroxy-2-piperidine ethyl carboxylate or / and (2S,5R)-N- Synthetic method of tert-butoxycarbonyl-5-hydroxy-2-piperidine ethyl carboxylate. Background technique [0002] Pipecolic acid and its derivatives are very important synthetic intermediates. The six-membered ring piperidine structure of this type of compound has two hand-shaped centers, which is very difficult to synthesize. Generally, it can be synthesized through very complicated synthetic steps. Used in the preparation of drugs such as Avibactam sodium and many biologically active substances. However, the current market price is very expensive, which not only limits its application in the pharmaceutical industry and the organic synthesis of complex natural products, but also greatly increases the cost of medicines that use it as a raw material. [0003] [0004] As an exis...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D211/60
CPCC07D211/60Y02P20/55
Inventor 王涛杜良栋应晓宁陈新志吴国锋
Owner ZHEJIANG MEDICINE CO LTD XINCHANG PHAMACEUTICAL FACTORY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products